1
|
Bordin DS, Embutnieks YV, Vologzhanina LG, Il'chishina TA, Voinovan IN, Sarsenbaeva AS, Alekseenko SA, Zaitsev OV, Abdulkhakov RA, Osipenko MF, Livzan MA, Tsukanov VV, Burkov SG, Bakulina NV, Dekhnich NN, Tarasova LV, Plotnikova EY, Maev IV, Kucheryavyi YA, Baryshnikova NV, Butov MA, Kolbasnikov SV, Pakhomova AL, Zhestkova TV, Baranovskii AY, Abdulkhakov SR, Ageeva EA, Lyalyukova EA, Vasyutin AV, Golubev NN, Savilova IV, Morkovkina LV, Kononova AG, Megraud F, O'Morain C, Ramas M, Nyssen OP, McNicholl AG, Gisbert JP. European Registry on the management of Helicobacter pylori infection (Hp-EuReg): analysis of 2360 patients receiving first-line therapy in Russia. TERAPEVT ARKH 2019; 90:35-42. [PMID: 30701770 DOI: 10.26442/terarkh201890235-42] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
AIM European Registry on the management of Helicobacter pylori infection («Hp-EuReg») - a multicenter prospective observational study initiated by the European Helicobacter and Microbiota Study Group, conducted in 27 European countries in order to evaluate the real clinical practice of diagnosis and treatment of H. pylori and its comparison with international recommendations. MATERIALS AND METHODS The analysis of 2360 patients entered in the register by the Russian centres of «Hp-EuReg» in 2013-2017, who were underwent 1st line eradication therapy. RESULTS The most common methods of primary diagnosis of H. pylori are histological (37.7%), rapid urease test (29.2%) and serology (29.7%). The duration of eradication therapy in 9.4% of cases was 7 days, in 65.3% - 10 days, and in 25.3% - 14 days. To control the effec- tiveness of treatment, H. pylori antigen in feces (31.3%), urea breath test (23.4%) and histological method (23.3%) were used. In 3.6% cases was used serology by mistake. In 17.3% of patients control was not carried out. The effectiveness of triple therapy with a PPI, amoxicillin, clar- ithromycin (per protocol) was 67.6%, with 7-day course, 81.1% at 10-day and 86.7% at 14-day course. Eradication rate of triple therapy with addition of bismuth (per protocol) reached 90,6% in the group receiving 10-day scheme and 93.6% in the group receiving the 14-day treatment. CONCLUSION Significant deviations of clinical practice from expert recommendations, most pronounced at the stage of monitoring the effectiveness of therapy, were noted. The suboptimal efficacy of triple therapy is shown.
Collapse
Affiliation(s)
- D S Bordin
- A.S. Loginov Moscow clinical scientific practical center of Moscow Healthcare Department , Moscow, Russia.,Tver state medical University, Ministry of health of Russia, Tver, Russia
| | - Yu V Embutnieks
- A.S. Loginov Moscow clinical scientific practical center of Moscow Healthcare Department , Moscow, Russia
| | | | | | - I N Voinovan
- A.S. Loginov Moscow clinical scientific practical center of Moscow Healthcare Department , Moscow, Russia
| | - A S Sarsenbaeva
- South Ural state medical University, Ministry of Health of Russia, Chelyabinsk, Russia
| | - S A Alekseenko
- Far Eastern State Medical University, Ministry of Health of Russia, Khabarovsk, Russia
| | - O V Zaitsev
- The First clinical medical center, Kovrov, Russia
| | - R A Abdulkhakov
- Kazan state medical University, Ministry of Health of Russia, Kazan, Russia
| | - M F Osipenko
- Novosibirsk state medical University, Ministry of Health of Russia, Novosibirsk, Russia
| | - M A Livzan
- Omsk state medical University, Ministry of health of Russia, Omsk, Russia
| | - V V Tsukanov
- Krasnoyarsk scientific center of the Siberian branch of the Russian Academy of Sciences, separat of division "Scientific research Institute of medical problems of the North", Krasnoyarsk, Russia
| | - S G Burkov
- Polyclinic №3 of Department for presidential Affairs of the Russian Federation, Moscow, Russia
| | - N V Bakulina
- I.I. Mechnikov North-Western state medical University, Ministry health of Russia, St. Petersburg, Russia
| | - N N Dekhnich
- Smolensk state medical University Ministry of health of Russia, Smolensk, Russia
| | - L V Tarasova
- Republican gastroenterology center, "Republican clinical hospital", Ministry of health of Chuvash Republic, I.N. Ulyanov state University, Cheboksary, Russia
| | - E Yu Plotnikova
- Kemerovo state medical University, Ministry health of Russia, Kemerovo, Russia
| | - I V Maev
- A.I. Evdokimov Moscow state medical dental University, Ministry of Health of Russia, Moscow, Russi
| | - Yu A Kucheryavyi
- A.I. Evdokimov Moscow state medical dental University, Ministry of Health of Russia, Moscow, Russi
| | - N V Baryshnikova
- Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia, St. Petersburg, Russia
| | - M A Butov
- I.P. Pavlov Ryazan State Medical University, Ministry of health of Russia, Ryazan, Russia
| | - S V Kolbasnikov
- Tver state medical University, Ministry of health of Russia, Tver, Russia
| | - A L Pakhomova
- V. I. Razumovsky Saratov state medical University, Ministry of health of Russia, Saratov, Russia
| | - T V Zhestkova
- I.P. Pavlov Ryazan State Medical University, Ministry of health of Russia, Ryazan, Russi
| | | | - S R Abdulkhakov
- Kazan state medical University, Ministry of Health of Russia, Kazan, Russia.,Kazan (Volga region) Federal University, Kazan, Russia
| | - E A Ageeva
- Far Eastern State Medical University, Ministry of Health of Russia, Khabarovsk, Russia
| | - E A Lyalyukova
- Omsk state medical University, Ministry of health of Russia, Omsk, Russia
| | - A V Vasyutin
- Krasnoyarsk scientific center of the Siberian branch of the Russian Academy of Sciences, separat of division "Scientific research Institute of medical problems of the North", Krasnoyarsk, Russia
| | - N N Golubev
- Polyclinic №3 of Department for presidential Affairs of the Russian Federation, Moscow, Russia
| | - I V Savilova
- I.I. Mechnikov North-Western state medical University, Ministry health of Russia, St. Petersburg, Russia
| | - L V Morkovkina
- Republican gastroenterology center, "Republican clinical hospital", Ministry of health of Chuvash Republic, I.N. Ulyanov state University, Cheboksary, Russia
| | - A G Kononova
- Tver state medical University, Ministry of health of Russia, Tver, Russia
| | - F Megraud
- Laboratoire of Bacteriology, Hospital Pellegrin, Bordeaux, France
| | - C O'Morain
- Department of Gastroenterology, Tallaght Hospital/Trinity College Dublin, Dublin, Ireland
| | - M Ramas
- Gastroenterology Unit, University Hospital «Princess», the Institute of Research in Health "Princess" (IIS-IP), Biomedical Research Centre Network of Hepatic and Digestive Diseases (CIBERehd), and Autonomous University of Madrid (UAM), Madrid, Spain
| | - O P Nyssen
- Gastroenterology Unit, University Hospital «Princess», the Institute of Research in Health "Princess" (IIS-IP), Biomedical Research Centre Network of Hepatic and Digestive Diseases (CIBERehd), and Autonomous University of Madrid (UAM), Madrid, Spain
| | - A G McNicholl
- Gastroenterology Unit, University Hospital «Princess», the Institute of Research in Health "Princess" (IIS-IP), Biomedical Research Centre Network of Hepatic and Digestive Diseases (CIBERehd), and Autonomous University of Madrid (UAM), Madrid, Spain
| | - J P Gisbert
- Gastroenterology Unit, University Hospital «Princess», the Institute of Research in Health "Princess" (IIS-IP), Biomedical Research Centre Network of Hepatic and Digestive Diseases (CIBERehd), and Autonomous University of Madrid (UAM), Madrid, Spain
| |
Collapse
|
2
|
Bordin DS, Embutnieks YV, Vologzhanina LG, Ilchishina TA, Voynovan IN, Sarsenbaeva AS, Zaitsev OV, Alekseenko SA, Abdulkhakov RA, Dehnich NN, Osipenko MF, Livzan MA, Tsukanov VV, Burkov SG, Bakulina NV, Plotnikova EY, Tarasova LV, Maev IV, Kucheryavyi YA, Baryshnikova NV, Butov MA, Kolbasnikov SV, Pakhomova AL, Zhestkova TV, Baranovsky AY, Abdulhakov SR, Ageeva EA, Lyalyukova EA, Vasyutin AV, Golubev NN, Savilova IV, Morkovkina LV, Kononova AG, Megraud F, O'Morain C, Ramas M, Nyssen OP, McNicholl AG, Gisbert JP. [European registry Helicobacter pylori (Hp-EuReg): how has clinical practice changed in Russia from 2013 to 2018 years]. TERAPEVT ARKH 2019; 91:16-24. [PMID: 32598623 DOI: 10.26442/00403660.2019.02.000156] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/11/2020] [Indexed: 12/25/2022]
Abstract
The multicenter prospective observational study initiated by the European Helicobacter and Microbiota Study Group (EHMSG) is conducted in 27 countries in Europe. The data from the Russian part of the European registry for the management of Helicobacter pylori infection (European Registry on the management of Helicobacter pylori infection, protocol: "Hp-EuReg") allows us to analyze the real clinical practice of diagnosis and treatment of H. pylori and compare it with international recommendations. MATERIALS AND METHODS A comparative analysis of the data entered in the register by the Russian research centers "Hp-EuReg", in the period from 2013 to 2018, was conducted. RESULTS AND DISCUSSION Invasive diagnostic methods prevail for the primary diagnosis of H. pylori [histology - 20.3% (in 2013 year) - 43.9% (in 2018 year), rapid urease test - 31.7% and 47.8% respectively]. The most popular mode of eradication therapy is a 10-day triple therapy (62.8-76.2%), the effectiveness of which does not exceed 79% (per protocol). Invasive tests (histology) are the leading method for control the effectiveness of therapy, however, there is a tendency towards a wider use of non-invasive methods (H. pylori stool antigen - from 17% in 2013 to 29.3% in 2018 and urea breath test from 6.9 to 18.3%, respectively). Serological test to control the effectiveness of eradication is still used from 8.2% (2013) to 6.1% (2018). Eradication therapy was not performed in 28% of patients throughout the entire observation period. CONCLUSION In Russia, despite approved domestic and international recommendations, deviations in clinical practice persist, both during eradication therapy and in monitoring the effectiveness of eradication therapy.
Collapse
Affiliation(s)
- D S Bordin
- A.S. Loginov Moscow Clinical Research and Practical Center of the Department of Health of Moscow
| | - Y V Embutnieks
- A.S. Loginov Moscow Clinical Research and Practical Center of the Department of Health of Moscow
| | | | | | - I N Voynovan
- A.S. Loginov Moscow Clinical Research and Practical Center of the Department of Health of Moscow
| | - A S Sarsenbaeva
- South Ural State Medical University of the Ministry of Health of the Russian Federation
| | | | - S A Alekseenko
- Far-Eastern State Medical University of the Ministry of Health of the Russian Federation
| | - R A Abdulkhakov
- Kazan State Medical University of the Ministry of Health of the Russian Federation
| | - N N Dehnich
- Smolensk State Medical University of the Ministry of Health of the Russian Federation
| | - M F Osipenko
- Novosibirsk State Medical University of the Ministry of Health of the Russian Federation
| | - M A Livzan
- Omsk State Medical University of the Ministry of Health of the Russian Federation
| | - V V Tsukanov
- Research Institute for Medical Problems of the North
| | - S G Burkov
- Polyclinic № 3 of the Department for Presidential Affairs of the Russian Federation
| | - N V Bakulina
- I.I. Mechnikov North-Western State Medical University of the Ministry of Health of the Russian Federation
| | - E Y Plotnikova
- Kemerovo State Medical Academy of the Ministry of Health of the Russian Federation
| | - L V Tarasova
- Republican Gastroenterology Center, Republican Clinical Hospital of the Ministry of Health and Social Development of Chuvashia.,I.N. Ulyanov Chuvash State University
| | - I V Maev
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian Federation
| | - Y A Kucheryavyi
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian Federation
| | - N V Baryshnikova
- I.P. Pavlov First Saint Petersburg State Medical University of the Ministry of Health of the Russian Federation
| | - M A Butov
- I.P. Pavlov Ryazan State Medical University of the Ministry of Health of the Russian Federation
| | - S V Kolbasnikov
- Tver State Medical University of the Ministry of Health of the Russian Federation
| | | | - T V Zhestkova
- I.P. Pavlov Ryazan State Medical University of the Ministry of Health of the Russian Federation
| | | | - S R Abdulhakov
- Kazan State Medical University of the Ministry of Health of the Russian Federation.,Kazan Federal University
| | - E A Ageeva
- Municipal outpatient clinic №3, Ministry of Health of Khabarovsk Region
| | - E A Lyalyukova
- Omsk State Medical University of the Ministry of Health of the Russian Federation
| | - A V Vasyutin
- Research Institute for Medical Problems of the North
| | - N N Golubev
- Polyclinic № 3 of the Department for Presidential Affairs of the Russian Federation
| | - I V Savilova
- I.I. Mechnikov North-Western State Medical University of the Ministry of Health of the Russian Federation
| | - L V Morkovkina
- Republican Gastroenterology Center, Republican Clinical Hospital of the Ministry of Health and Social Development of Chuvashia
| | - A G Kononova
- Tver State Medical University of the Ministry of Health of the Russian Federation
| | - F Megraud
- Laboratoire de Bactériologie, Hôpital Pellegrin
| | - C O'Morain
- Department of Gastroenterology, Tallaght Hospital/Trinity College Dublin
| | - M Ramas
- Gastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), and Universidad Autónoma de Madrid (UAM)
| | - O P Nyssen
- Gastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), and Universidad Autónoma de Madrid (UAM)
| | - A G McNicholl
- Gastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), and Universidad Autónoma de Madrid (UAM)
| | - J P Gisbert
- Gastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), and Universidad Autónoma de Madrid (UAM)
| |
Collapse
|
3
|
Taboada M, Calvo A, Doldán P, Ramas M, Torres D, González M, Rodríguez A, Lombardía M, Fernandez C, Baluja A, Otero P, Álvarez J. Are «off hours» intubations a risk factor for complications during intubation? A prospective, observational study. Med Intensiva 2017; 42:527-533. [PMID: 29275003 DOI: 10.1016/j.medin.2017.10.010] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2017] [Revised: 10/24/2017] [Accepted: 10/25/2017] [Indexed: 12/24/2022]
Abstract
OBJECTIVE To compare the complications and the difficulty of orotracheal intubation procedures performed in the Intensive Care Unit during the off-hours period and the on-hours period. DESIGN A prospective, observational and non-interventional cohort study covering a period of 27 months was carried out. Working days between 8:00 a. m. and 7:59 p. m. were considered «on-hours», while the remaining shifts were regarded as «off-hours». SCOPE An 18-bed surgical in a Intensive Care Unit of a third-level hospital. PATIENTS All orotracheal intubation patients admitted to the ICU from January 2015 to March 2017 were included. Patients were stratified into 2groups according to whether intubation was performed on-hours or off-hours. INTERVENTIONS Non-interventional study. VARIABLES OF INTEREST The reason for intubation, time and day on which intubation was performed, degree of intubation difficulty (number of attempts, Cormack-Lehane laryngoscopic vision, need for accessory material) and complications during intubation. RESULTS A total of 252 patients were intubated; of these, 132 were included in the on-hours group and 120 patients in the off-hours group. In the off-hours group we observed a greater percentage of urgent and emergent intubations compared to the on-hours group. However, no differences were found between the 2groups in relation to the other variables studied. CONCLUSIONS During the off-hours period, orotracheal intubation was not associated to a greater number of complications or to greater difficulty of the technique in our Unit.
Collapse
Affiliation(s)
- M Taboada
- Unidad de Cuidados Críticos Postoperatorios, Servicio de Anestesiología y Reanimación, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, España.
| | - A Calvo
- Unidad de Cuidados Críticos Postoperatorios, Servicio de Anestesiología y Reanimación, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, España
| | - P Doldán
- Unidad de Cuidados Críticos Postoperatorios, Servicio de Anestesiología y Reanimación, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, España
| | - M Ramas
- Unidad de Cuidados Críticos Postoperatorios, Servicio de Anestesiología y Reanimación, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, España
| | - D Torres
- Unidad de Cuidados Críticos Postoperatorios, Servicio de Anestesiología y Reanimación, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, España
| | - M González
- Unidad de Cuidados Críticos Postoperatorios, Servicio de Anestesiología y Reanimación, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, España
| | - A Rodríguez
- Unidad de Cuidados Críticos Postoperatorios, Servicio de Anestesiología y Reanimación, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, España
| | - M Lombardía
- Unidad de Cuidados Críticos Postoperatorios, Servicio de Anestesiología y Reanimación, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, España
| | - Cr Fernandez
- Unidad de Cuidados Críticos Postoperatorios, Servicio de Anestesiología y Reanimación, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, España
| | - A Baluja
- Unidad de Cuidados Críticos Postoperatorios, Servicio de Anestesiología y Reanimación, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, España
| | - P Otero
- Unidad de Cuidados Críticos Postoperatorios, Servicio de Anestesiología y Reanimación, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, España
| | - J Álvarez
- Unidad de Cuidados Críticos Postoperatorios, Servicio de Anestesiología y Reanimación, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, España
| |
Collapse
|
4
|
Chaparro M, Ramas M, Benítez JM, López-García A, Juan A, Guardiola J, Mínguez M, Calvet X, Márquez L, Fernández Salazar LI, Bujanda L, García C, Zabana Y, Lorente R, Barrio J, Hinojosa E, Iborra M, Cajal MD, Van Domselaar M, García-Sepulcre MF, Gomollón F, Piqueras M, Alcaín G, García-Sánchez V, Panés J, Domènech E, García-Esquinas E, Rodríguez-Artalejo F, Gisbert JP. Extracolonic Cancer in Inflammatory Bowel Disease: Data from the GETECCU Eneida Registry. Am J Gastroenterol 2017; 112:1135-1143. [PMID: 28534520 DOI: 10.1038/ajg.2017.96] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/06/2016] [Accepted: 12/29/2016] [Indexed: 12/11/2022]
Abstract
OBJECTIVES The objective of this study was (a) To know the prevalence and distribution of extracolonic cancer (EC) in patients with inflammatory bowel disease (IBD); (b) To estimate the incidence rate of EC; (c) To evaluate the association between EC and treatment with immunosuppressants and anti-tumor necrosis factor (TNF) agents. METHODS This was an observational cohort study. INCLUSION CRITERIA IBD and inclusion in the ENEIDA Project (a prospectively maintained registry) from GETECCU. EXCLUSION CRITERIA Patients with EC before the diagnosis of IBD, lack of relevant data for this study, and previous treatment with immunosuppressants other than corticosteroids, thiopurines, methotrexate, or anti-TNF agents. The Kaplan-Meier method was used to evaluate the impact of several variables on the risk of EC, and any differences between survival curves were evaluated using the log-rank test. Stepwise multivariate Cox regression analysis was used to investigate factors potentially associated with the development of EC, including drugs for the treatment of IBD, during follow-up. RESULTS A total of 11,011 patients met the inclusion criteria and were followed for a median of 98 months. Forty-eight percent of patients (5,303) had been exposed to immunosuppressants or anti-TNF drugs, 45.8% had been exposed to thiopurines, 4.7% to methotrexate, and 21.6% to anti-TNF drugs. The prevalence of EC was 3.6%. In the multivariate analysis, age (HR=1.05, 95% CI=1.04-1.06) and having smoked (hazards ratio (HR)=1.47, 95% confidence interval (CI)=1.10-1.80) were the only variables associated with a higher risk of EC. CONCLUSIONS Neither immunosuppressants nor anti-TNF drugs seem to increase the risk of EC. Older age and smoking were associated with a higher prevalence of EC.
Collapse
Affiliation(s)
- María Chaparro
- Hospital de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain
| | - M Ramas
- Hospital de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain
| | - J M Benítez
- Hospital Reina Sofía, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain
| | | | - A Juan
- Hospital Germans Trias i Pujol (CIBERehd), Badalona, Spain
| | - J Guardiola
- Badalona, Hospital Bellvitge, Barcelona, Spain
| | - M Mínguez
- Hospital Clínico de Valencia, Valencia, Spain
| | - X Calvet
- Hospital Parc Taulí, Barcelona, Spain
| | | | | | - L Bujanda
- Hospital Donostia (CIBERehd), Universidad del País Vasco (UPV/EHU), San Sebastián, Spain
| | - C García
- Hospital Ramón y Cajal, Madrid, Spain
| | - Y Zabana
- Hospital Mutua de Terrassa (CIBERehd), Terrassa, Spain
| | - R Lorente
- Hospital General Universitario de Ciudad Real, Ciudad Real, Spain
| | - J Barrio
- Hospital Universitario Río Hortega, Valladolid, Spain
| | | | - M Iborra
- Hospital La Fe (CIBERehd), Valencia, Spain
| | | | | | | | - F Gomollón
- ISS Aragón, Hospital Clínico "Lozano Blesa" (CIBERehd), Zaragoza, Spain
| | | | - G Alcaín
- Hospital Clínico Universitario de Málaga, Málaga, Spain
| | - V García-Sánchez
- Hospital Reina Sofía, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain
| | - J Panés
- Hospital Clinic (CIBERehd), Barcelona, Spain
| | - E Domènech
- Hospital Germans Trias i Pujol (CIBERehd), Badalona, Spain
| | - E García-Esquinas
- Department of Preventive Medicine and Public Health, Universidad Autónoma de Madrid/IdiPaz and CIBER of Epidemiology and Public Health (CIBERESP), Madrid, Spain
| | - F Rodríguez-Artalejo
- Department of Preventive Medicine and Public Health, Universidad Autónoma de Madrid/IdiPaz and CIBER of Epidemiology and Public Health (CIBERESP), Madrid, Spain
| | - J P Gisbert
- Hospital de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain
| |
Collapse
|
5
|
Ramas M. Freud's Dora, Dora's hysteria: the negation of a woman's rebellion. Fem Stud 2001; 6:472-510. [PMID: 11616967] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/21/2023]
|